Khadija Tejjani

Research output

Research output per year 2021 2022 2024

• 11 Article
• 1 Meeting Abstract

Research output per year

Research output per year

Search results

• 2024

  Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients

  Bondt, A., Hoek, M., Dingess, K., Tamara, S., de Graaf, B., Peng, W., den Boer, M. A., Damen, M., Zwart, C., Barendregt, A., van Rijswijck, D. M. H., Schulte, D., Grobben, M., Tejjani, K., van Rijswijk, J., Völlmy, F., Snijder, J., Fortini, F., Papi, A., Volta, C. A., & 6 othersCampo, G., Contoli, M., van Gils, M. J., Spadaro, S., Rizzo, P. & Heck, A. J. R., 1 Jan 2024, In: Molecular and Cellular Proteomics. 23, 1, 100690.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• The Impact of First-Time SARS-CoV-2 Infection on Human Anelloviruses

  Timmerman, A. L., Commandeur, L., Deijs, M., Burggraaff, M. G. J. M., Lavell, A. H. A., van der Straten, K., Tejjani, K., van Rijswijk, J., van Gils, M. J., Sikkens, J. J., Bomers, M. K. & van der Hoek, L., 9 Jan 2024, In: Viruses. 16, 1, 99.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2023

  Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity

  VACOPID Research Group, Aug 2023, In: Journal of clinical immunology. 43, 6, p. 1104-1117 14 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

  AGEhIV Cohort Study, 1 May 2023, In: Microbiology spectrum. 11, 3, p. e0115523 20 p., e0115523.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)
• 2022

  Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

  van Gils, M. J., Lavell, A., van der Straten, K., Appelman, B., Bontjer, I., Poniman, M., Burger, J. A., Oomen, M., Bouhuijs, J. H., van Vught, L. A., Slim, M. A., Schinkel, M., Wynberg, E., van Willigen, H. D. G., Grobben, M., Tejjani, K., van Rijswijk, J., Snitselaar, J. L., Caniels, T. G., Vlaar, A. P. J., & 6 othersPrins, M., de Jong, M. D., de Bree, G. J., Sikkens, J. J., Bomers, M. K. & Sanders, R. W., 1 May 2022, In: PLoS medicine. 19, 5, e1003991.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  57 Citations (Scopus)

• A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

  van der Velden, Y. U., Grobben, M., Caniels, T. G., Burger, J. A., Poniman, M., Oomen, M., Rijnstra, E. S., Tejjani, K., Guerra, D., Kempers, R., Stegmann, T., van Gils, M. J. & Sanders, R. W., 1 Dec 2022, In: Scientific reports. 12, 1, 3884.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  11 Citations (Scopus)

• A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

  RECoVERED Study Group, 18 Jan 2022, In: Cell Reports Medicine. 3, 1, 100486.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  13 Citations (Scopus)

• Decreased Passive Immunity to Respiratory Viruses through Human Milk during the COVID-19 Pandemic

  Grobben, M., Juncker, H. G., van der Straten, K., Lavell, A. H. A., Schinkel, M., Buis, D. T. P., Wilbrink, M. F., Tejjani, K., Claireaux, M. A. F., Aartse, A., de Groot, C. J. M., Pajkrt, D., Bomers, M. K., Sikkens, J. J., van Gils, M. J., van Goudoever, J. B. & van Keulen, B. J., 31 Aug 2022, In: Microbiology spectrum. 10, 4, p. e0040522

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  7 Citations (Scopus)

• Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

  Keuning, M. W., Grobben, M., Bijlsma, M. W., Anker, B., Berman-de Jong, E. P., Cohen, S., Felderhof, M., de Groen, A-E., de Groof, F., Rijpert, M., van Eijk, H. W. M., Tejjani, K., van Rijswijk, J., Steenhuis, M., Rispens, T., Plötz, F. B., van Gils, M. J. & Pajkrt, D., 9 Sept 2022, In: Frontiers in immunology. 13, 976382.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  5 Citations (Scopus)

• Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

  Brouwer, P. J. M., Antanasijevic, A., Ronk, A. J., Müller-Kräuter, H., Watanabe, Y., Claireaux, M., Perrett, H. R., Bijl, T. P. L., Grobben, M., Umotoy, J. C., Schriek, A. I., Burger, J. A., Tejjani, K., Lloyd, N. M., Steijaert, T. H., van Haaren, M. M., Sliepen, K., de Taeye, S. W., van Gils, M. J., Crispin, M., & 4 othersStrecker, T., Bukreyev, A., Ward, A. B. & Sanders, R. W., 14 Dec 2022, In: CELL Host & Microbe. 30, 12, p. 1759-1772.e12

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  15 Citations (Scopus)
• 2021

  Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

  Amsterdam UMC COVID-19 S3/HCW study group, 1 Oct 2021, In: eBioMedicine. 72, 103589.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  14 Citations (Scopus)